ARALEZ PHARMACEUTICALS INC. Depreciation and Amortization
ARALEZ PHARMACEUTICALS INC. reported Depreciation and Amortization of $9.37 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for the quarter ending 2018-03-31 was $9.37M, a 5.52% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for the quarter ending 2017-12-31 was $8.98M, a 29.26% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for the quarter ending 2017-09-30 was $9.04M, a 256.26% increase year-over-year.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for the quarter ending 2017-06-30 was $8.90M.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for fiscal 2017 was $35.80M, a 176.07% increase from fiscal 2016.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for fiscal 2016 was $12.97M, a 80950.00% increase from fiscal 2015.
- ARALEZ PHARMACEUTICALS INC. depreciation, depletion and amortization for fiscal 2015 was $16.00K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2018-03-31 | $9.37M 10-Q · filed 2018-05-08 | $18.35M derived: sum of 2 quarters · filed 2018-05-08 | $27.39M derived: sum of 3 quarters · filed 2018-05-08 | $36.29M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | $8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $18.02M derived: sum of 2 quarters · filed 2018-03-14 | $26.93M derived: sum of 3 quarters · filed 2018-03-14 | $35.80M 10-K · filed 2018-03-14 |
| 2017-09-30 | $9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $17.94M derived: sum of 2 quarters · filed 2017-11-09 | $26.82M 10-Q · filed 2017-11-09 | $33.77M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-06-30 | $8.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $17.78M 10-Q · filed 2017-08-09 | $24.73M derived: sum of 3 quarters · filed 2018-05-08 | $27.26M derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-03-31 | $8.88M 10-Q · filed 2018-05-08 | $15.82M derived: sum of 2 quarters · filed 2018-05-08 | $18.36M derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $9.49M derived: sum of 2 quarters · filed 2018-03-14 | $12.97M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $6.02M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $3.48M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $16.00K 10-K · filed 2018-03-14 |